Cadmium and atherosclerosis: Heavy metal or singing the blues?

Atherosclerosis

Volumn 249, Issue , 2016, Pages 230-232

  Santos Gallego, Carlos G ^a   Jialal, Ishwarlal ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Atherosclerosis; Cadmium; Inflammation; Oxidative stress; Smoking

Indexed keywords

CADMIUM; CD68 ANTIGEN; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 1BETA; INTERLEUKIN 6; METALLOTHIONEIN; MONOCYTE CHEMOTACTIC PROTEIN 1; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; VASCULAR CELL ADHESION MOLECULE 1; HEAVY METAL;

ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAROTID ATHEROSCLEROSIS; CEREBROVASCULAR ACCIDENT; ENDOTHELIAL DYSFUNCTION; ENVIRONMENTAL EXPOSURE; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; LEAFY VEGETABLE; NONHUMAN; NOTE; PASSIVE SMOKING; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; SMOKING; SOIL POLLUTION; OXIDATIVE STRESS;

ATHEROSCLEROSIS; CADMIUM; HUMANS; METALS, HEAVY; OXIDATIVE STRESS;

EID: 84989911089     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2016.01.041     Document Type: Note

References (39)

1. [1] Nordberg, G.F., Fowler, B.A., Nordberg, M., Handbook on the Toxicology of Metals. fourth ed., 2014, Elsevier.
2. [2] Fransson, M.N., Barregard, L., Sallsten, G., Akerstrom, M., Johanson, G., Physiologically-based toxicokinetic model for cadmium using Markov-chain Monte Carlo analysis of concentrations in blood, urine, and kidney cortex from living kidney donors. Toxicol. Sci. 141 (2014), 365–376.
3. [3] Park, J.D., Cherrington, N.J., Klaassen, C.D., Intestinal absorption of cadmium is associated with divalent metal transporter 1 in rats. Toxicol. Sci. 68 (2002), 288–294.
4. [4] Cosselman, K.E., Navas-Acien, A., Kaufman, J.D., Environmental factors in cardiovascular disease. Nat. Rev. Cardiol. 12 (2015), 627–642.
5. [5] Carroll, R.E., The relationship of cadmium in the air to cardiovascular disease death rates. JAMA 198 (1966), 267–269.
6. [6] Aalbers, T.G., Houtman, J.P., Relationships between trace elements and atherosclerosis. Sci. Total Environ. 43 (1985), 255–283.
7. [7] Nakagawa, H., Nishijo, M., Morikawa, Y., et al. Urinary cadmium and mortality among inhabitants of a cadmium-polluted area in Japan. Environ. Res. 100 (2006), 323–329.
8. [8] Nawrot, T.S., Van Hecke, E., Thijs, L., et al. Cadmium-related mortality and long-term secular trends in the cadmium body burden of an environmentally exposed population. Environ. Health Perspect. 116 (2008), 1620–1628.
9. [9] Everett, C.J., Frithsen, I.L., Association of urinary cadmium and myocardial infarction. Environ. Res. 106 (2008), 284–286.
10. [10] Peters, J.L., Perlstein, T.S., Perry, M.J., McNeely, E., Weuve, J., Cadmium exposure in association with history of stroke and heart failure. Environ. Res. 110 (2010), 199–206.
11. [11] Menke, A., Muntner, P., Silbergeld, E.K., Platz, E.A., Guallar, E., Cadmium levels in urine and mortality among U.S. adults. Environ. Health Perspect. 117 (2009), 190–196.
12. [12] Tellez-Plaza, M., Guallar, E., Howard, B.V., et al. Cadmium exposure and incident cardiovascular disease. Epidemiology 24 (2013), 421–429.
13. [13] Tellez-Plaza, M., Navas-Acien, A., Menke, A., Crainiceanu, C.M., Pastor-Barriuso, R., Guallar, E., Cadmium exposure and all-cause and cardiovascular mortality in the U.S. general population. Environ. Health Perspect. 120 (2012), 1017–1022.
14. [14] Messner, B., Knoflach, M., Seubert, A., et al. Cadmium is a novel and independent risk factor for early atherosclerosis mechanisms and in vivo relevance. Arterioscler. Thromb. Vasc. Biol. 29 (2009), 1392–1398.
15. [15] Fagerberg, B., Barregard, L., Sallsten, G., et al. Cadmium exposure and atherosclerotic carotid plaques–results from the Malmo diet and Cancer study. Environ. Res. 136 (2015), 67–74.
16. [16] Navas-Acien, A., Selvin, E., Sharrett, A.R., Calderon-Aranda, E., Silbergeld, E., Guallar, E., Lead, cadmium, smoking, and increased risk of peripheral arterial disease. Circulation 109 (2004), 3196–3201.
17. [17] Tellez-Plaza, M., Navas-Acien, A., Crainiceanu, C.M., Sharrett, A.R., Guallar, E., Cadmium and peripheral arterial disease: gender differences in the 1999-2004 US National health and Nutrition Examination Survey. Am. J. Epidemiol. 172 (2010), 671–681.
18. [18] Tellez-Plaza, M., Jones, M.R., Dominguez-Lucas, A., Guallar, E., Navas-Acien, A., Cadmium exposure and clinical cardiovascular disease: a systematic review. Curr. Atheroscler. Rep., 15, 2013, 356.
19. [19] Fagerberg, B., Bergstrom, G., Boren, J., Barregard, L., Cadmium exposure is accompanied by increased prevalence and future growth of atherosclerotic plaques in 64-year-old women. J. Intern Med. 272 (2012), 601–610.
20. [20] Bergstrom, G., Fagerberg, B., Sallsten, G., Lundh, T., Barregard, L., Is cadmium exposure associated with the burden, vulnerability and rupture of human atherosclerotic plaques?. PLoS One, 10, 2015, e0121240.
21. [21] Fagerberg, B., Kjedlldahl, J., Sällsten, G., et al. Cadmium exposure as measured in blood in relation to macrophage density in symptomatic atherosclerotic plaques from human carotid artery. Atherosclerosis, 2016, 10.1016/j.atherosclerosis.2016.01.11.
22. [22] Jialal, I., Rajamani, U., Adams-Huet, B., Kaur, H., Circulating pathogen-associated molecular pattern - binding proteins and High Mobility Group Box protein 1 in nascent metabolic syndrome: implications for cellular Toll-like receptor activity. Atherosclerosis 236 (2014), 182–187.
23. [23] Tellez-Plaza, M., Navas-Acien, A., Crainiceanu, C.M., Guallar, E., Cadmium exposure and hypertension in the 1999-2004 National health and Nutrition Examination Survey (NHANES). Environ. Health Perspect. 116 (2008), 51–56.
24. [24] Akesson, A., Lundh, T., Vahter, M., et al. Tubular and glomerular kidney effects in Swedish women with low environmental cadmium exposure. Environ. Health Perspect. 113 (2005), 1627–1631.
25. [25] Navas-Acien, A., Tellez-Plaza, M., Guallar, E., et al. Blood cadmium and lead and chronic kidney disease in US adults: a joint analysis. Am. J. Epidemiol. 170 (2009), 1156–1164.
26. [26] Hellstrom, L., Elinder, C.G., Dahlberg, B., et al. Cadmium exposure and end-stage renal disease. Am. J. Kidney Dis. 38 (2001), 1001–1008.
27. [27] Knoflach, M., Messner, B., Shen, Y.H., et al. Non-toxic cadmium concentrations induce vascular inflammation and promote atherosclerosis. Circ. J. 75 (2011), 2491–2495.
28. [28] Messner, B., Bernhard, D., Cadmium and cardiovascular diseases: cell biology, pathophysiology, and epidemiological relevance. Biometals 23 (2010), 811–822.
29. [29] Jomova, K., Valko, M., Advances in metal-induced oxidative stress and human disease. Toxicology 283 (2010), 65–87.
30. [30] Cuypers, A., Plusquin, M., Remans, T., et al. Cadmium stress: an oxidative challenge. Biometals 23 (2010), 927–940.
31. [31] Messner, B., Turkcan, A., Ploner, C., Laufer, G., Bernhard, D., Cadmium overkill: autophagy, apoptosis and necrosis signalling in endothelial cells exposed to cadmium. Cell Mol. Life Sci., 2015, 10.1007/S00018-015-2094-9.
32. [32] Bilgen, I., Oner, G., Edremitlioglu, M., Alkan, Z., Cirrik, S., Involvement of cholinoceptors in cadmium-induced endothelial dysfunction. J. Basic Clin. Physiol. Pharmacol. 14 (2003), 55–76.
33. [33] Almenara, C.C., Broseghini-Filho, G.B., Vescovi, M.V., et al. Chronic cadmium treatment promotes oxidative stress and endothelial damage in isolated rat aorta. PLoS One, 8, 2013, e68418.
34. [34] Stoica, A., Katzenellenbogen, B.S., Martin, M.B., Activation of estrogen receptor-alpha by the heavy metal cadmium. Mol. Endocrinol. 14 (2000), 545–553.
35. [35] Liu, Y., Li, Y., Liu, K., Shen, J., Exposing to cadmium stress cause profound toxic effect on microbiota of the mice intestinal tract. PLoS One, 9, 2014, e85323.
36. [36] Wang, Z., Klipfell, E., Bennett, B.J., et al. Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease. Nature 472 (2011), 57–63.
37. [37] Park, S.L., Kim, Y.M., Ahn, J.H., et al. Cadmium stimulates the expression of vascular cell adhesion molecule-1 (VCAM-1) via p38 mitogen-activated protein kinase (MAPK) and JNK activation in cerebrovascular endothelial cells. J. Pharmacol. Sci. 110 (2009), 405–409.
38. [38] Fagerberg, B., Bergstrom, G., Boren, J., Barregard, L., Cadmium exposure, intercellular adhesion molecule-1 and peripheral artery disease: a cohort and an experimental study. BMJ Open, 3, 2013.
39. [39] Santos-Gallego, C.G., Picatoste, B., Badimon, J.J., Pathophysiology of acute coronary syndrome. Curr. Atheroscler. Rep., 16, 2014, 401.